| Date Filed | Type | Description |
| 12/02/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 12/01/2022 |
SC 13G/A
| Flynn James E reports a 0% stake in Frazier Lifesciences Acquisition Corp. |
| 11/25/2022 |
SC 13D/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in Frazier Lifesciences Acquisition Corporation |
| 11/25/2022 |
4
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Converted 2,459,880 shares
@ $0
Converted 1,211,582 shares
@ $0 |
|
| 11/23/2022 |
8-K
| Appointed a new director|
Docs:
|
"Amended and Restated Memorandum and Articles of Association of the Surviving Company",
"Certificate of Incorporation of Frazier Lifesciences Acquisition Corporation",
"Bylaws of Frazier Lifesciences Acquisition Corporation",
"Warrant Assignment, Assumption and Amendment Agreement, between Continental Stock Transfer & Trust Company, NewAmsterdam Pharma Company B.V. and Frazier Lifesciences Acquisition Corporation",
"NewAmsterdam Pharma Debuts as Publicly Traded Company Focused on Developing Obicetrapib, a Low-Dose, Once-Daily Oral LDL-Lowering Agent with Promising Safety and Efficacy Clinical Data, as a Potential Preferred Therapy for High Risk Cardiovascular Disease Patients" |
|
| 11/23/2022 |
4
| Topper David Joseph (CFO) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Exercised 30,000 options to buy
@ $0 |
|
| 11/23/2022 |
4
| BIGHAM MICHAEL (Director) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Exercised 30,000 options to buy
@ $0 |
|
| 11/23/2022 |
4
| Polu Krishna R (Director) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Exercised 30,000 options to buy
@ $0 |
|
| 11/23/2022 |
4
| Baltera Robert Jr. (Director) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Exercised 30,000 options to buy
@ $0 |
|
| 11/23/2022 |
4
| Gallagher Carol Giltner (Director) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Exercised 30,000 options to buy
@ $0 |
|
| 11/23/2022 |
SC 13D/A
| Frazier Lifesciences Sponsor LLC reports a 0% stake in Frazier Lifesciences Acquisition Corporation |
| 11/22/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/22/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/22/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 11/16/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 11/15/2022 |
8-K
| Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits &... |
| 11/14/2022 |
3
| Flynn James E (10% Owner) has filed a Form 3 on Frazier Lifesciences Acquisition Corp |
| 11/14/2022 |
SC 13G
| Flynn James E reports a 17.3% stake in Frazier Lifesciences Acquisition Corp. |
| 11/09/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
3
| VIKING GLOBAL INVESTORS LP (10% Owner) has filed a Form 3 on Frazier Lifesciences Acquisition Corp |
| 11/03/2022 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 10/18/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 10/17/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/13/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/11/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/05/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/05/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 10/04/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/29/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/28/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/23/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/22/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
| 09/21/2022 |
425
| Form 425 - Prospectuses and communications, business combinations: |
|